Home Drug Codes J Codes J9267 · Paclitaxel
Updated July 1st, 2026

Paclitaxel J Code: J9267

Injection, paclitaxel, 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9267, effective October 1, 2026: $0.108 per HCPCS billing unit, down 3.6% from $0.112. From CMS's final file.

?
Medicare Payment Limit ?
$0.112
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
41
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, paclitaxel, 1 mg
HCPCS Added Date January 1, 2015
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Multi-Dose
Dosage Form Injection | Injection, Solution | Injection, Solution, Concentrate | Not Available

About Paclitaxel

Paclitaxel is a medication aligned to the HCPCS J Code: J9267 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: Paclitaxel is used to treat various types of cancer. It is a cancer chemotherapy drug that works by slowing or stopping cancer cell growth.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 41 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00703-3213-01 Paclitaxel Teva Parenteral Medicines, Inc. 30 30 MG / 5 ML
16714-0137-01 Paclitaxel Northstar Rx LLC 300 300 MG / 50 ML
23155-0882-31 Paclitaxel Paclitaxel Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 30 30 MG / 5 ML
25021-0255-05 Paclitaxel Sagent Pharmaceuticals 30 30 MG / 5 ML
61703-0015-04 Paclitaxel Hospira, Inc. 30 30 MG / 5 ML
•••••-••••-•• Log in to view Paclitaxel
Paclitaxel
Paclitaxel
Login to view 36 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Paclitaxel Pricing & Reimbursement

J9267 Private Payer Reimbursement
$0.12 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

Paclitaxel 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J9264 Generic Code (Multiple Manufacturers) Paclitaxel Injection, paclitaxel protein-bound particles, 1 mg
J9267 Generic Code (Multiple Manufacturers) Paclitaxel Injection, paclitaxel, 1 mg

Paclitaxel CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Paclitaxel (J9267) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9267. Wastage billing guide →

Paclitaxel Medically Unlikely Edits (MUE)

The most billing units of J9267 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
750 units / day
= 750 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

Paclitaxel Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

AIDS-Related Kaposi's Sarcoma AIDS-related Kaposi's sarcoma Advanced carcinoma of the ovary Breast Cancer Breast cancer Carcinoma of the Ovary Carcinoma of the ovary Metastatic breast cancer Node-positive breast cancer Non-Small Cell Lung Cancer Non-small cell lung cancer
Drug Class
Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Paclitaxel billing and coding guide?
We have not yet identified a manufacturer source of Paclitaxel billing and coding information.
Are there any available Paclitaxel patient assistance programs?
Our team did not identify a source for Paclitaxel patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Paclitaxel prescribing information?
Our team is still working to identify a prescribing information source for Paclitaxel
Where can I find Paclitaxel side effect information?
Our team has not yet identified a source of side effects information for Paclitaxel. Please check back in a few weeks.
Does billing Paclitaxel require JZ/JW wastage modifiers?
CMS does not include Paclitaxel (J9267) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9267. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.